44,804 Shares in Maximus, Inc. (NYSE:MMS) Purchased by New Age Alpha Advisors LLC

New Age Alpha Advisors LLC acquired a new stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 44,804 shares of the health services provider's stock, valued at approximately $3,345,000. New Age Alpha Advisors LLC owned about 0.08% of Maximus at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Nordea Investment Management AB purchased a new stake in Maximus in the 4th quarter worth approximately $4,618,000. Fort Washington Investment Advisors Inc. OH lifted its stake in Maximus by 39.1% in the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 296,476 shares of the health services provider's stock worth $22,132,000 after acquiring an additional 83,390 shares during the period. IFP Advisors Inc boosted its holdings in Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after acquiring an additional 302 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new position in Maximus in the 4th quarter worth $1,113,000. Finally, Legato Capital Management LLC lifted its position in shares of Maximus by 33.9% in the 4th quarter. Legato Capital Management LLC now owns 32,134 shares of the health services provider's stock worth $2,399,000 after purchasing an additional 8,138 shares during the period. 97.21% of the stock is owned by institutional investors.

Maximus Stock Down 1.8 %

MMS traded down $1.30 during trading on Thursday, reaching $69.73. The stock had a trading volume of 90,272 shares, compared to its average volume of 535,413. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The company has a market capitalization of $3.95 billion, a price-to-earnings ratio of 15.00 and a beta of 0.71. The stock's 50 day moving average is $69.44 and its two-hundred day moving average is $77.46. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.97.

Remove Ads

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Saturday, February 15th were given a $0.30 dividend. The ex-dividend date was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.72%. Maximus's dividend payout ratio is currently 25.81%.

Insider Buying and Selling

In related news, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the transaction, the director now owns 18,097 shares in the company, valued at $1,225,347.87. The trade was a 11.88 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the firm's stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now owns 2,512 shares of the company's stock, valued at approximately $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

MMS has been the subject of a number of research reports. StockNews.com downgraded shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Raymond James upgraded Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price on the stock in a report on Thursday, January 2nd.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.